Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Changes in excitability and ion channel expression in neurons of the major pelvic ganglion in female type II diabetic mice.

Gray M, Lett KM, Garcia VB, Kyi CW, Pennington KA, Schulz LC, Schulz DJ.

Auton Neurosci. 2019 Sep;220:102558. doi: 10.1016/j.autneu.2019.102558. Epub 2019 Jun 15.

PMID:
31331692
2.

Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial.

Kyi C, Roudko V, Sabado R, Saenger Y, Loging W, Mandeli J, Thin TH, Lehrer D, Donovan M, Posner M, Misiukiewicz K, Greenbaum B, Salazar A, Friedlander P, Bhardwaj N.

Clin Cancer Res. 2018 Oct 15;24(20):4937-4948. doi: 10.1158/1078-0432.CCR-17-1866. Epub 2018 Jun 27.

3.

Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab.

Friedlander P, Wassmann K, Christenfeld AM, Fisher D, Kyi C, Kirkwood JM, Bhardwaj N, Oh WK.

J Immunother Cancer. 2017 Aug 15;5(1):67. doi: 10.1186/s40425-017-0272-z.

4.

The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma.

Del Castillo M, Romero FA, Arg├╝ello E, Kyi C, Postow MA, Redelman-Sidi G.

Clin Infect Dis. 2016 Dec 1;63(11):1490-1493. Epub 2016 Aug 7.

5.

Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges.

Kyi C, Postow MA.

Immunotherapy. 2016 Jun;8(7):821-37. doi: 10.2217/imt-2016-0002. Review.

6.

Nitroxides as anti-biofilm compounds for the treatment of Pseudomonas aeruginosa and mixed-culture biofilms.

Alexander SA, Kyi C, Schiesser CH.

Org Biomol Chem. 2015 Apr 28;13(16):4751-9. doi: 10.1039/c5ob00284b.

PMID:
25804546
7.

Controlling biofilms on cultural materials: the role of 3-(dodecane-1-thiyl)-4-(hydroxymethyl)-2,2,5,5-tetramethyl-1-pyrrolinoxyl.

Alexander SA, Rouse EM, White JM, Tse N, Kyi C, Schiesser CH.

Chem Commun (Camb). 2015 Feb 25;51(16):3355-8. doi: 10.1039/c4cc08390c.

PMID:
25621707
8.

Ipilimumab in patients with melanoma and autoimmune disease.

Kyi C, Carvajal RD, Wolchok JD, Postow MA.

J Immunother Cancer. 2014 Oct 14;2(1):35. doi: 10.1186/s40425-014-0035-z. eCollection 2014.

9.

Opportunistic infections in patients treated with immunotherapy for cancer.

Kyi C, Hellmann MD, Wolchok JD, Chapman PB, Postow MA.

J Immunother Cancer. 2014 Jun 18;2:19. doi: 10.1186/2051-1426-2-19. eCollection 2014.

10.

Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients.

Kitano S, Tsuji T, Liu C, Hirschhorn-Cymerman D, Kyi C, Mu Z, Allison JP, Gnjatic S, Yuan JD, Wolchok JD.

Cancer Immunol Res. 2013 Oct;1(4):235-44. doi: 10.1158/2326-6066.CIR-13-0068.

11.

A case report of trastuzumab dose in gastric cancer.

Kyi C, Shah MA.

J Gastrointest Oncol. 2013 Dec;4(4):E19-22. doi: 10.3978/j.issn.2078-6891.2013.015.

12.

Checkpoint blocking antibodies in cancer immunotherapy.

Kyi C, Postow MA.

FEBS Lett. 2014 Jan 21;588(2):368-76. doi: 10.1016/j.febslet.2013.10.015. Epub 2013 Oct 23. Review.

13.

A controlled clinical trial of the effects of the Twin Block and Dynamax appliances on the hard and soft tissues.

Lee RT, Kyi CS, Mack GJ.

Eur J Orthod. 2007 Jun;29(3):272-82. Epub 2007 Apr 24.

PMID:
17456506
14.

Treatment approaches for developmentally absent second premolars.

Kyi CS, Tredwin CJ, Naini FB.

Dent Update. 2006 May;33(4):228-30, 233-4, 237-40.

PMID:
16756238
16.

Use of a nasogastric catheter to prevent soft tissue entanglement of the externally ported distractor arm.

Kyi CS, Key SJ, Lloyd TW.

Int J Oral Maxillofac Surg. 2003 Jun;32(3):337-8.

PMID:
12767884

Supplemental Content

Support Center